- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Tick Bite.
Displaying page 1 of 1.
EudraCT Number: 2011-000117-39 | Sponsor Protocol Number: A2301 | Start Date*: 2011-06-14 | |||||||||||
Sponsor Name:Ixodes AG. | |||||||||||||
Full Title: A Phase 3 randomized, double-blind, placebo-controlled study of SHB004 (10% topical azithromycin) administered locally twice daily for three consecutive days for the prevention of Borreliosis in su... | |||||||||||||
Medical condition: Lyme borreliosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005101-51 | Sponsor Protocol Number: RIVM-V/330564/01 | Start Date*: 2013-02-05 | |||||||||||
Sponsor Name:National Institute of Health and the Environment (Dutch acronym: RIVM) | |||||||||||||
Full Title: Tick Test & Prophylaxis Proof | |||||||||||||
Medical condition: Lyme disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-009324-36 | Sponsor Protocol Number: B9371021_(Formerly_Baxter_700802) | Start Date*: 2009-03-04 | |||||||||||
Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: OPEN-LABEL PHASE IV STUDY TO INVESTIGATE THE SEROPERSISTENCE OF TICK-BORNE ENCEPHALITIS (TBE) VIRUS ANTIBODIES AFTER THE FIRST BOOSTER AND THE RESPONSE TO A SECOND BOOSTER VACCINATION WITH FSME-IMM... | |||||||||||||
Medical condition: Active (prophylactic) immunization against TBE The main purpose of this study is to assess the seropersistence of TBE virus antibodies in children, adolescents and young adults who received the fi... | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) DE (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004674-94 | Sponsor Protocol Number: WI237607 | Start Date*: 2019-04-05 | |||||||||||
Sponsor Name:Riga Stradiņš University | |||||||||||||
Full Title: Open-label Phase IV Study to Investigate Broad-and Cross-neutralizing Antibodies after Primary Vaccination with Two Different TBE Vaccines | |||||||||||||
Medical condition: Active (prophylactic) immunization against tick-borne encephalitis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023747-15 | Sponsor Protocol Number: 070411 | Start Date*: 2011-05-03 | |||||||||||
Sponsor Name:University of Oslo | |||||||||||||
Full Title: Tick borne diseases in norwegian general practice. A randomized, controlled trial for treatment of erythema migrans in norwegian general practice. A comparison of phneoxymetylpenicillin, amoxicilli... | |||||||||||||
Medical condition: Erythema migrans (Early Lyme disease) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.